Trademark: 87948687
Word
SYMPHEOS
Status
Dead
Status Code
606
Status Date
Monday, August 15, 2022
Serial Number
87948687
Mark Type
4000
Filing Date
Tuesday, June 5, 2018
Published for Opposition
Tuesday, May 14, 2019
Abandoned Date
Monday, August 15, 2022

Trademark Owner History
Abbott Laboratories - Owner At Publication

Classifications
41 Providing a website featuring non-downloadable instruction sheets and operating manuals for in vitro diagnostic instruments, laboratory automation systems, and related software
9 Research and commercial laboratory analyzers for measuring, testing and analyzing blood, bodily fluids and/or tissue; Laboratory instruments for in vitro diagnostic testing and/or analysis; Laboratory equipment for use in the field of medical diagnostics, namely, laboratory test and collection kits used in connection with in vitro diagnostics consisting of test tubes and microscope slides; Molecular diagnostic systems for the detection, quantitation, identification and functional analysis of nucleic acids, genetic materials, infectious agents and/or pathogens consisting of sequencers, spectrometers, sensors and computers; Automated clinical molecular instruments in the nature of sequencers, spectrometers, sensors and computers; Laboratory instruments for microbial screening and identification; Laboratory apparatus for genotyping, gene expression analysis, molecular imaging, and DNA sequence analysis; Laboratory test and collection kits used in connection with in vitro diagnostics comprising test tubes; Molecular diagnostic systems comprised of sequencers, spectrometers, sensors and computers, for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents or pathogens; automated clinical molecular laboratory instruments, namely, homogenizers; laboratory sample extraction instruments; laboratory instruments for microbial screening and identification; laboratory apparatus, namely, molecular diagnostic sensors for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; Data management and laboratory automation computer programs for use in the field of medical diagnostics; Computer hardware and software for use in the field of medical diagnostics; Data management software for medical diagnostic instruments; Data management software for hematology analyzers, clinical chemistry analyzers, immunoassay analyzers and blood screening instruments; Computer software and hardware for medical diagnostic instruments; Computer software and hardware for hematology analyzers, clinical chemistry analyzers, immunoassay analyzers and blood screening instruments; Computer software and hardware for managing interface between medical diagnostic laboratory instruments; Computer software and hardware for managing medical diagnostic laboratory workflow; Laboratory information management software and hardware for use in the field of medical diagnostics; Computer software and hardware for monitoring medical diagnostic instruments; Computer software and hardware for monitoring laboratory diagnostic instruments; Computer software and hardware for troubleshooting regarding medical diagnostic instruments; Computer software and hardware for troubleshooting regarding laboratory diagnostic instruments; Computer software for processing diagnostic medical testing data; Computer hardware and software for use in medical diagnostic testing; Computer hardware and software for remote monitoring of in vitro diagnostic instruments; Computer software and hardware for identification and analysis of nucleic acid sequences, nucleic acids for pathogen identity, drug resistance characteristics and forensic profiles; Computer software for front-end processing, instrument control, data analysis and reporting for molecular diagnostic instruments; Electronic publications, namely, instruction sheets and manuals for in vitro diagnostic instruments, laboratory automation systems recorded on computer media, and related software
5 Biological reagents and chemical reagents for medical purposes; medical diagnostic assays for testing of bodily fluids and tissue in the detection, monitoring, and/or prediction of disease or other conditions, disease states, hormone level, drug level, drug response, organ function effectiveness, and/or clinical response; diagnostic preparations for medical purposes; diagnostic test kits comprised of medical diagnostic reagents and assays for testing in the field of medical diagnostics
1 Control and calibrating reagents for medical diagnostic instruments; control and calibrating reagents for laboratory instruments used for in vitro diagnostic testing and/or analysis; diagnostic reagents for scientific or medical research use; diagnostic test kits consisting primarily of monoclonal antibodies, antigens, buffers, assay components and reagents for scientific or medical laboratory use
10 Hematology analyzers for medical diagnostic use; clinical chemistry analyzers for medical diagnostic use in testing bodily fluids; immunoassay analyzers for medical diagnostic use; blood screening instruments for medical use; medical diagnostic instruments for in vitro diagnostic testing and/or analysis; molecular diagnostic instruments for the analysis of body fluids; medical diagnostic instruments, namely, sample handlers, sample preparation equipment, equipment for testing bodily fluids for medical diagnosis; specimen collection kits used in connection with in vitro diagnostics comprising sample collection tubes all for medical use
42 Providing technical support services regarding in vitro diagnostic laboratory instruments, laboratory automation systems, and related software and hardware, namely, troubleshooting in the nature of diagnosing problems with medical equipment; Providing technical support, namely, troubleshooting of problems in the field of laboratory software in the field of in vitro diagnostics; Providing remote electronic troubleshooting services in the nature of diagnosing problems with medical diagnostic instruments and software for laboratories in the field of in vitro diagnostics; Providing operational monitoring services for laboratory equipment in the field of in vitro diagnostics; Remote monitoring of medical diagnostic laboratory systems to ensure proper functioning; Providing remote electronic monitoring of in vitro diagnostic equipment and laboratory automation systems to ensure proper functioning; Platform as a service (PAAS) featuring computer platform for laboratory and diagnostic equipment information management, monitoring and analysis in the field of in vitro diagnostics; Software as a service (SAAS) services featuring software for use in managing data and information in the field of medical diagnostics

Trademark Events
Aug 15, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 15, 2022
Abandonment - No Use Statement Filed
Jan 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 14, 2022
Sou Extension 5 Granted
Jan 7, 2022
Sou Extension 5 Filed
Jan 14, 2022
Case Assigned To Intent To Use Paralegal
Jan 7, 2022
Sou Teas Extension Received
Jul 2, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 30, 2021
Sou Extension 4 Granted
Jun 30, 2021
Sou Extension 4 Filed
Jun 30, 2021
Sou Teas Extension Received
Dec 19, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 17, 2020
Sou Extension 3 Granted
Dec 17, 2020
Sou Extension 3 Filed
Dec 17, 2020
Sou Teas Extension Received
Jun 27, 2020
Notice Of Approval Of Extension Request E-Mailed
Jun 25, 2020
Sou Extension 2 Granted
Jun 25, 2020
Sou Extension 2 Filed
Jun 25, 2020
Sou Teas Extension Received
Jan 11, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 9, 2020
Sou Extension 1 Granted
Jan 9, 2020
Sou Extension 1 Filed
Jan 9, 2020
Sou Teas Extension Received
Jul 9, 2019
Noa E-Mailed - Sou Required From Applicant
May 14, 2019
Official Gazette Publication Confirmation E-Mailed
May 14, 2019
Published For Opposition
Apr 24, 2019
Notification Of Notice Of Publication E-Mailed
Apr 9, 2019
Approved For Pub - Principal Register
Mar 26, 2019
Teas/Email Correspondence Entered
Mar 26, 2019
Correspondence Received In Law Office
Mar 14, 2019
Teas Response To Office Action Received
Sep 25, 2018
Combined Examiner's Amendment/Priority Action Entered
Sep 25, 2018
Assigned To Lie
Sep 25, 2018
Notification Of Examiner's Amendment/Priority Action E-Mailed
Sep 25, 2018
Examiner's Amendment/Priority Action E-Mailed
Sep 25, 2018
Examiners Amendment And/Or Priority Action - Completed
Sep 24, 2018
Assigned To Examiner
Jun 11, 2018
New Application Office Supplied Data Entered
Jun 8, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24